Cerebral amyloid angiopathy (CAA) is a cerebrovascular condition marked by the deposition of amyloid‐β (Aβ) within the walls of cerebral vessels, frequently encountered in the elderly and often in ...
A 74-year-old man with an unremarkable medical history noted a progressive gait disorder in the months prior to admission. His wife recalled increased sleepiness and loss of initiative. After having ...
CAMBRIDGE, Mass. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today positive interim results from the ...
MONTREAL--(BUSINESS WIRE)--AmorChem is proud to announce a new investment in a research program hailing from Université Laval and the Research Center of the Centre Hospitalier Universitaire de Québec.
Cerebral amyloid angiopathy (CAA) is a condition where protein (called amyloid) builds up in the brain, making blood vessels weak. People with CAA are four times more likely to develop dementia within ...
Please provide your email address to receive an email when new articles are posted on . Cerebral amyloid angiopathy was associated with a higher risk for isolated nontraumatic subdural hemorrhage in ...
A common type of brain bleed in older adults, known as subdural hemorrhage, is associated with the presence of amyloid deposits in cerebral blood vessels, according to a study led by researchers at ...
Bright spots called white-matter hyperintensities (WMHs) often appear on MRI scans of people with familial or sporadic Alzheimer’s disease, and they tend to intensify as the disease progresses. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results